|
Market Closed -
London S.E.
08:22:35 2025-10-24 EDT
|
5-day change | 1st Jan Change | ||
| 6.451 SEK | -23.88% |
|
+51.79% | +41.78% |
| 10-08 | 36 stocks have hit new 52-week lows so far today on the Stockholm Stock Exchange | FW |
| 10-07 | 20 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
Company Valuation: Active Biotech AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 275.5 | 254.8 | 165.1 | 115.9 | 121.3 | 91.08 | - | - |
| Change | - | -7.51% | -35.2% | -29.8% | 4.6% | -24.89% | - | - |
| Enterprise Value (EV) | 223.1 | 254.8 | 128.9 | 88.53 | 121.3 | 91.08 | 91.08 | 91.08 |
| Change | - | 14.2% | -49.4% | -31.34% | 36.97% | -24.89% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - | - | -5.55x |
| EV / Revenue | - | - | - | - | - | - | - | -5.55x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -2.62x | 5.49x | 1.81x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -2.74x | 5x | 1.76x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | -16.4 |
| EBITDA 1 | -48.5 | -56.4 | -44.8 | -38.2 | -36 | -34.8 | 16.6 | 50.2 |
| EBIT 1 | -49.8 | -57.9 | -46.5 | -39.8 | -37.6 | -33.2 | 18.2 | 51.8 |
| Net income 1 | -49.8 | -58.4 | -45.8 | -39.4 | -37.32 | -33.2 | 18.2 | 51.8 |
| Net Debt | -52.37 | - | -36.2 | -27.4 | - | - | - | - |
| Reference price 2 | 126.400 | 96.200 | 45.650 | 10.880 | 4.600 | 3.455 | 3.455 | 3.455 |
| Nbr of stocks (in thousands) | 2,180 | 2,649 | 3,617 | 10,655 | 26,361 | 26,361 | - | - |
| Announcement Date | 3/25/22 | 2/9/23 | 2/8/24 | 2/13/25 | 4/1/26 | - | - | - |
1SEK in Million2
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.5x | 7.3x | 14.66x | 1.45% | 70.65B | |
| 27.57x | 7.54x | 23.67x | 0.05% | 51.22B | |
| 33.47x | 6.01x | 18.01x | 0.97% | 48.04B | |
| 33.77x | 3.27x | 14.13x | -.--% | 43.16B | |
| -20.11x | 203.7x | -21.41x | -.--% | 41.57B | |
| 46.41x | 5.27x | 28.96x | -.--% | 39.84B | |
| 27.3x | 7.78x | 20.18x | 0.42% | 30.87B | |
| 31.79x | 6.78x | 17.59x | -.--% | 27.53B | |
| -14.56x | 5.85x | -7.07x | -.--% | 24.08B | |
| Average | 20.68x | 28.17x | 12.08x | 0.32% | 41.88B | |
| Weighted average by Cap. | 22.04x | 28.06x | 13.06x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ACTI Stock
- 0GQU Stock
- Valuation Active Biotech AB
Select your edition
All financial news and data tailored to specific country editions
